Denosumab. Riesgo de osteonecrosis mandibular. AEMPS

by Colfar | junio 26, 2019 10:40 am

Farmacovigilancia. Denosumab. Riesgo de Osteonecrosis mandibular

Source URL: https://colfarsfe.org.ar/2019/06/26/denosumab-riesgo-de-osteonecrosis-mandibular-aemps/